University of Rochester Wilmot Cancer Inst.

601 Elmwood Avenue
Rochester, New York 14642

We've found

1 trials

at this facility

A Study of Ibrutinib + Obinutuzumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Rochester, NY

Use our guide to learn which trials are right for you!